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a b s t r a c t
Due to increasing regulatory awareness of their hepatotoxic, genotoxic and possibly carcinogenic poten-
tial, pyrrolizidine alkaloid (PA) content has to be thoroughly monitored in herbal medicinal preparations.
Recently, new very low PA regulatory threshold concentrations have been requested by the author-
ities. Therefore, a highly sensitive and reproducible UPLC TOF MS method for the quantiﬁcation of
the PAs senkirkine, senecionine, seneciphylline, senecionine-N-oxide and seneciphylline-N-oxide in a
CO2-extract of Petasites hybridus leaves (Ze 339) has been developed.
The limit of quantiﬁcation (LOQ) was 2ppb for all PAs. Recovery at the LOQ was between 88.9 and
141.9%, the repeatability precision between 3.5 and 13.6%. Linearity of the ﬁve PAs showed correlation
coefﬁcients between 0.9995 and 0.9998 and coefﬁcients of variation between 7.44 and 8.56%. A working
range between 2 ppb and 200 ppb could be ﬁxed. In the tested batches of the P. hybridus extract Ze
339, the absence of PAs could be demonstrated. In conclusion, this assay allows to determine trace PA
concentrations in P. hybridus extract Ze 339,making it suitable for analytical PAmonitoring in accordance
with regulatory requirements.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Since, the discovery of 1,2-unsaturated pyrrolizidine alkaloids
(PA) in medicinal plants and herbal medicines in the 1970s and
the recognition of their toxicity to humans, such as veno-occlusive
disease, genotoxicity and possibly cancer, there have been a huge
number of publications for the quantitative analysis of these sub-
stances. At the beginning of PA analysis, gas chromatographic
(GC) methods with ﬂame ionization (FID) or nitrogen–phosphorus
(NPD) detection as well as high pressure liquid chromatography
(HPLC) methods with ultraviolet light (UV) detection had been
used, preferentially. All of these methods, which are still used in PA
analysis, are, however, confounded with some serious disadvan-
tages. Thus, for example, the PA-N-oxides are not detected directly
by gas chromatography, which necessitates their previous reduc-
tion to the corresponding free bases. HPLC-UV methods have the
disadvantage that a low and non-speciﬁc wavelength (220nm) is
required to detect the unsaturated PAs and therefore, the choice
of solvents is limited. Both types of chromatography, combined
with conventional detectors cannot longer withstand the enor-
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mous increase in requirements for a high speciﬁcity and sensitivity
in PA analysis. For these reasons, LC–MS-methods came more and
more into focus, since they allow reliably identiﬁcation of the ana-
lytes with a substantially improved sensitivity (for an overview of
the different methodological approaches see [1]).
Regulatory authorities demand the reliable quantiﬁcation of
PAs in a very low concentration range (trace analysis) for herbal
food and pharmaceutical preparations: In 2011, the European Food
Safety Authority (EFSA) proposed a limit for the human daily intake
of 1,2-unsaturated PAs of 70g/kg b.w. by food products [2]. The
Australia New Zealand Food Authority (ANZFA) deﬁned in 2001
a provisional tolerable daily intake for PAs in humans as 1g/kg
b.w. [3]. In 2014, the British Committee on Toxicity of Chemicals
in Food, Consumer Products and the Environment (COT) deﬁned a
safe dose of PAs of 0.007g/kg b.w./day [4]. For genotoxic impu-
rities, a threshold value for lifelong oral intake of 1.5g/day was
deﬁned by the International Conference on Harmonization (ICH
M7) [5]. Recently, the Committee on Herbal Medicinal Products
(HMPC) of the European Medicines Agency (EMA) required a limit
of 0.35g per day for short-term (≤14 days) oral administration
from all sources (herbal medicinal preparations and food). Beyond
this treatment period, noPAs are allowed [6]. Therefore, for a longer
treatment with herbal preparations, the demonstration of absence
of PAs is mandatory. However, this requires a highly sensitive and
http://dx.doi.org/10.1016/j.jchromb.2015.05.027
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speciﬁc analytical method for the detection of PAs in the herbal
extract.
Since, there are approximately 600 different PAs known, which
naturally occur indifferentplants [2], an appropriate selectionof PA
reference standards is needed. In the case of Petasites hybridus (but-
terbur), the selection of relevant (naturally occurring) PA species
was guided by previous reports of PA occurrence in this plant [7–9].
The determination of PAs in plant material or herbal extracts,
especially at higher concentrations is considerably inﬂuenced by
matrix effects. Among these, interferences of the PA-peaks with
matrix substances with approximately the same mass often lead
to false positive results, especially when single-stage MS was used.
Matrix effects may be resolved ﬁrst by the reduction of the con-
centration of test solutions, while using modern sensitive mass
spectrometers [1], and secondly, by enhancing concentration of
analytes during the sample preparation, for example by the appli-
cation of solid phase extraction (SPE) [10,11]. Most importantly,
the PA levels in samples had to be compared to reference standards
thatwere analysed inPA-freematrix. Last butnot least, the interfer-
ence problemmay be resolved by using tandemmass spectrometry
applications (MS–MS) [12,13], single/multiple reaction monitoring
technique (SRM/MRM) [12] or mass spectrometers with very high
mass-accuracy and -resolution.
Thismanuscript describes the development of amatrix-speciﬁc,
highly sensitive and reproducible ultra-performance liquid chro-
matography (UPLC) – high-resolution MS TOF method, which
allows the trace analysis of PAs in P. hybridus extract Ze 339.
Objectives of the development of the method were to achieve
the simplest possible but exhaustive sample preparation, a fast
and highly resolving UPLC separation system and a highly spe-
ciﬁc single-stageHRMS-timeof ﬂight (TOF) detection,which avoids
interference with matrix substances as far as possible.
2. Materials and methods
2.1. Petasites hybridus Ze 339
For method development and validation, different lots of liquid
P. hybridus extract Ze 339were used,whichwere produced by CO2-
extraction of the dried and ﬁne cut leaves of P. hybridus with a
drug-extract ratio (DER) of 50–100:1. The extract presents itself as
an oily viscose and almost clear liquid. The P. hybridus extract Ze
339 is registered for the treatment of allergic rhinitis in Switzerland
and other countries and was provided by Max Zeller Söhne AG,
Romanshorn, Switzerland. PAs were efﬁciently removed from the
extract duringextractionprocedureby theuseof a speciﬁc absorber
technique.
2.2. Alkaloid reference standards
Senkirkine, senecionine, seneciphylline, senocionine-N-oxide,
and seneciphylline-N-oxide used as external standards were
obtained from PhytoLab GmbH & Co. KG, Germany. Purity was
between 89% (senecionine-N-oxide), 98% (senkirkine) and >99%
(senecionine, seneciphylline and seneciphylline-N-oxide).
2.3. Matrix solution/reference standards
In several available batches of P. hybridus extract, Ze 339 PA
content was measured by this method. From these batches, one
was chosen with non-quantiﬁable PA content and served as a
basis for the preparation of matrix solution. To 1.5 g PA free
P. hybridus extract Ze 339 2mL of dichloromethane was given
and mixed brieﬂy using the test tube shaker. After addition of
4mL of acetic acid 10% (v/v) and mixing for 10min on an over-
head shaker (30 rpm), the solution was centrifuged for 5min at
5000 rpm (3885× g). The upper aqueous phase was removed, and
dichloromethanephasewasextractedagainwith4mLofacetic acid
10% (v/v). The aqueous phaseswere uniﬁed and 1mL of 25% ammo-
nia solution (v/v) was added. Acetic acid 10% (v/v) was added up
to a ﬁnal volume of 10mL. The prepared matrix solution was used
for preparing the reference solutions. For this purpose, 10mL of
matrix solution was required per reference concentration. Inter-
nal and external reference standards were dissolved in methanol
at concentrations of 10g/mL and 500g/mL, respectively. Refer-
ence standards were further diluted with acetic acid 10% (v/v) to
achieve concentrations of 40, 125, and 300ng/mL.
These dilutions were added to the prepared matrix solution
to achieve matrix based reference standards at ten different con-
centration levels (0.3, 0.6, 1.3, 3.0, 6.3, 9.0, 12.5, 15.0, 22.5 and
30.0ng/mL corresponding to 2.0, 4.0, 8.3, 20.0, 41.7, 60.0, 83.3,
100.0, 150.0 and 200.00ppb).
2.4. Test solution
1.5 g P. hybridus extract Ze 339 was treated as described for
matrix solution. The obtained solution was centrifuged over 5min
at 10,000 rpm (12,678× g).
2.5. Liquid chromatography
A Waters Acquity H-Class UPLC-system (Waters, Milford, MA,
USA) including a vacuum solvent degassing unit, a quarternary
high pressure gradient pump, an automatic sample injector and a
column thermostat were used. Chromatographic separation was
achieved on an Acquity BEH C18, 1.7m, 75×2.1mm column
(Waters, Manchester, UK). The mobile phase consisted of 5mM
aqueous ammoniumacetate buffer (pH8.5) (A) and acetonitrile (B).
The initial gradient condition was 98% A and 2% B linearly changed
to 34% B over 8min, followed by a step to 90% B until 8.10min,
held until 11.00min and turned back to initial condition until 11.10
and washed by this until 15.00min. The column temperature was
adjusted at 50 ◦C. The ﬂow rate was 0.6mL/min and the injection
volume was 4L.
2.6. Mass spectrometry
Mass spectrometry was performed in positive electrospray
modeusing ahigh resolutionmass spectrometer synaptG2SHDMS
(Waters, Manchester, UK) with a TOF-detector with linear dynamic
range of at least 5000:1, a mass resolution of minimum 30,000
FWHM (full peak width at half-maximum) at m/z 400 and a triple
quadrupolewith 4kDa. The desolvation gas (45 ◦C, 800 L/h) and the
nebulizer gas (6.0 bar) were nitrogen. The cone gas had a ﬂow of
50 L/h. The capillary voltage was 0.50kV and the source tempera-
ture 120 ◦C.
For the generation of mass spectra as for assessing, the identity
of unknown PAs trap collision and transfer collision voltagewas set
at 4V. The analyser mode was set at ‘resolution’ and the dynamic
range at ‘extended’. The mass spectra were acquired over the range
of 50–600Da with a spectral acquisition rate of 0.1 s per spec-
trum. Real time mass correction was performed using a solution
of 0.5ng/mL of leucine enkephalin (C28H37N5O7 at m/z 555.62).
2.7. Calculation
The content of eachof PAwas calculated fromacalibration curve
that was generated using the same alkaloid as an external standard
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Table 1
Characteristics of used reference standards.
Group PA Rt (min) [M+H]+
Sencionine-type PA Senecionine 6.8 336.182
Senecionine-N-oxide 4.2 352.176
Seneciphylline 6.1 334.165
Seneciphylline-N-oxide 3.5 350.160
Otosenine-type PAs Senkirkine 4.5 366.191
Rt = retention time.
(see Table 1) using the TargetLynx software (Waters, Manchester,
UK) as follows:
PA(ppb) = (y − b) × v
m × iw × 1000
where y= area respectively area corrected by external standard;
b=ordinate intersection; m= slope of standard curves; V= sample
volume (mL); 1000= conversion factor from mg to g; iw= initial
weight in mg.
2.8. Validation
The assay was validated according to the ICH guideline of vali-
dation of analytical procedures [14].
The identity of PAswas assuredby their retention time andmass
(±0.001Da) in comparison to the reference standards.
Selectivity was determined in blank matrix solution (see above).
Recovery was determined in ﬁve concentrations and 5 repeats.
Intermediate precision was analysed on two different levels (60
ppb and 150 ppb) by a second analyst.
Accuracy was tested at ﬁve concentrations (e.g. 2, 4, 20, 60, and
150 ppb; N=6). At the lower two concentrations (e.g. 2 and 4ppb)
correlation coefﬁcient (CV) limit was ≤25%, at the other concentra-
tions ≤10%.
Linearity was shown for each external standards with 10 con-
centrations over a range of 2–200 ppb; N=3. In order to minimize
matrix effects, analysis of external standards was done in matrix
solutions of PA-free P. hybridus extract.
Limit of quantiﬁcation (LOQ) based on linearity data for each PA,
the LOQ was deﬁned at the lowest concentration of the standard
concentration range.
Robustness: The stability of reference solution in PA free matrix
was assessed after storing at room temperature and exposed to
light for one week. The stability of test solutions was assessed at
storage at 4 ◦C for 6 weeks. The acceptance criterion of±10% devi-
ation related to the fresh prepared solutions was fulﬁlled for all
reference PAs.
System suitability test (SST) was based on requirements of the
Ph. Eur. Chapter 2.2.46 on different samples. The symmetry factor
of the senkirkine peak and the coefﬁcient of variation of repeated
injections of a standard solution had to be between 0.8 and 1.5 and
<3% (N=6 injections), respectively.
Table 2
Recovery (%) of PAs at each of the quality control levels (ppb).
PA 2.0ppb 4.0ppb 20ppb 60ppb 150ppb
Senecionine 88.3 95.5 80.8 89.0 84.9
Senecionine-N-oxide 89.5 78.8 82.5 89.5 88.3
Seneciphylline 141.9 109.2 87.9 89.5 90.2
Seneciphylline-N-oxide 91.0 88.8 88.0 93.2 89.6
Senkirkine 108.3 109.0 89.8 94.3 98.3
Table 4
Inter-serial variability (N=6). CV%.
Levels 60ppb 150ppb
Senecionine 1.33 2.20
Senecionine-N-oxide 5.31 1.48
Seneciphylline 1.22 1.79
Seneciphylline-N-oxide 1.62 2.47
Senkirkine 2.29 2.50
Table 5
Linearity (10 concentrations over a range of 2–200 ppb; N=3).
Standards R2 Slope Intercept CV%
Senecionine 0.99961 392.6 540.1 a 7.4
Senecionine-N-oxide 0.99975 270.9 8.656 5.9
Seneciphylline 0.99948 366.1 383.0 a 8.6
Seneciphylline-N-oxide 0.99961 237.8 0.465 7.5
Senkirkine 0.99949 304.8 314.8 a 8.5
a Signiﬁcant intercept.
3. Results and discussion
The structural formulas of internal and external standards of
the PAs are shown in Fig. 1. Sample chromatograms of internal and
external PA standards are given in Fig. 2. The identity of PAs was
assured by their retention time and accurate mass (±0.001Da) in
comparison to the reference standards (Table 1).
SelectivitywasdeterminedwithPA-freematrix. Retention times,
and exact masses of the spiked samples were comparable with the
References
Recovery (Table 2) over the whole range of tested con-
centrations was 80.8–95.5% for senecionine, 78.8–89.5% for
senecionine-N-oxide, 141.9% for 2ppb seneciphylline, 87.9–109.2%
for 4–150ppb, and 88.0–93.2% for seneciphylline-N-oxide. The
higher recovery rate of seneciphylline at 2ppb corresponds with
other results on trace analysis [15]. The accuracy (Table 3) was
lower than 5% with the exception of the two lower levels, where it
was below 24%.
Assessment of intermediate precision showed that the variances
of both series were homogeneous and the means were not signif-
icantly different. The coefﬁcients of variation of the intermediate
precision were within the acceptance criterion of <10%. Intra- and
inter-serial variabilities were ≤10%. The results give ﬁrst indica-
tion, that the method is precise and robust to a second analyst’s
inﬂuence (Tables 3 and 4).
Table 3
Mean accuracy (Repeatability) (N=6). (ppb) / (CV%).
Nominal concentrations (ppb)
2 4 20 60 150
Senecionine 2.0/5.4 4.0/23.7 20.2/1.9 60.6/4.1 151.5/4.4
Senecionine-N-oxide 1.7/13.8 3.4/22.8 17.0/1.5 50.9/3.3 127.1/3.5
Seneciphylline 2.0/3.6 4.0/7.2 20.1/1.7 60.2/3.8 150.4/4.6
Seneciphylline-N-oxide 1.9/11.3 3.8/12.8 19.0/1.2 57.1/1.7 142.9/2.5
Senkirkine 1.9/5.4 3.7/23.7 18.7/1.9 56.2 / 4.2 140.5/2.5
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Fig. 1. Structural formulas of internal and external PAs.
Linearity was established in a concentration range of 2–200ppb
(Table 5). Statistical evaluation showed that for each PA linear
regression was justiﬁed.
The ﬁve reference PAs in PA-free P. hybridus extract demon-
strated a linear correlation within the concentrations from 0.3 to
30ng/mL, deﬁning the working range of the method. This approxi-
mately corresponds to a range of 2–200ppb of each PA in a sample
of P. hybridus extract Ze 339.
Based on linearity data for each PA, the LOQ was 2 ppb for
each standard. Thepeaks at this concentrationhadbeenunambigu-
ously identiﬁed, and quantiﬁcation was accurate and reproducible
(CV%≤20).
Several methodological approaches have been discussed in
the literature to reliably measure and quantify PAs in dif-
ferent biological matrices, by gas chromatography ([16–19])
and liquid chromatography with following mass spectroscopy
([8,10,17,18,20–30]).
Besides a lower sensitivity than LC–MS/MS methods ([17]), GC
based methods have the principal drawback, that PA N-oxides
are not directly determinable and require reduction to transform
them into tertiary amines prior to determination. Thus, liquid
chromatography (HPLC, UPLC) based methods coupled with HRMS
techniques become more and more the standard in PA detection
and quantiﬁcation due to their high sensitivity and speciﬁcity.
Several other LC–MS methods for the determination of PAs,
which were analysed in different matrices, have been published
with a similar sensitivity [8,18,24,26,27,30,31]. However, all of
them had only a low mass resolution, and most of them used MRM
technique and/or determined LOQ in matrix free solution, only.
All robustness tests (see Table 6) fulﬁlled the condition of a
prediction interval. This interval was calculated by the standard
deviation of the repeatability precision.
Table 6
Parameters of robustness analysis (acceptance criterion).
Parameters of robustness
UHPLC-conditions
Different batches of the stationary phase
Variation of the column temperature (± 5 ◦C)
Variation of the ﬂow (± 0.05mL/ min)
Variation of pH-value of the buffer (eluent A)
Variation of% eluent B (organic solvent)
MS-conditions
Variation of the capillary voltage (±2kV)
Variation of the cone voltage (5V)
Variation of the desolvation temperature (±50%)
3.1. Selection of PA standards
In previous experiments (data not shown), we had used retror-
sine and retrorsine-N-oxide as external standards to quantify PA
content in matrix. However, these approaches were not successful.
The different degrees of ionization of each PA, especially the sub-
stance speciﬁc impact of matrix effects on the ionization leading to
different responses of the analytes, required the determination of
speciﬁc correction factors for each PA. Compared with retrorsine,
the same quantity of seneciphylline and senecionine gave approx-
imately a two-fold different peak area. A correction factor of 0.51
has been calculated. With regard to senkirkine, this factor had to be
set to 0.27. Onedifﬁcultywas, however, that determinationof these
factors required the availability of the respective PA reference. For
PAs, where no reference standard is available, quantiﬁcation was
not reliable. In those preliminary investigations, the lack of high
mass accuracy of the MS led to false positive results. This effect
was even more pronounced, the closer PA content was measured
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Extracted mass 350.160 
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Senkirkine, Rt 4.5min
Standard chromatogram 
containing 60 ppb PA in matrix BPI
Fig. 2. Standard chromatograms of internal and external PAs showing retention times and exact masses ([M+H]+). In addition, a chromatogram is given, where PAs were
spiked to matrix base peak intensity (BPI).
to the LOQ. In order to identify PA reliably as such and to quantify
them against a standard with the same response, it was decided to
measure eachPAagainst a reference substanceof the samealkaloid.
Theuseofhigh-resolutionmass spectrometry,with additional frag-
mentation experiments and the consideration of retention times
allowed a sufﬁciently reliable identiﬁcation of PAs.
During validation, the possible advantage of using internal stan-
dards (retrorsine and retrorsine-N-oxide) was evaluated (Table 8).
This analysis showed that anadditional internal PA standarddidnot
improve variability in linearity and precision assessment. There-
fore, use of internal standards was omitted.
The industrial extraction process of P. hybridus extract Ze 339
was designed to completely remove PAs present in the dried leaves
as raw material. Therefore, we had to use not properly puriﬁed
extract batches, to identify, which alkaloids, present in the dried
leaves of P. hybridus, might migrate from dried leaves into the liq-
uid extract during the extraction process. Hereby,we could identify
senkirkine, senecionine, seneciphylline, senocionine-N-oxide and
seneciphylline N-oxide, which all were available as reference stan-
dards.
Since other PAs (such as 7− and 9-angeloylretronecine and their
N-oxides, integerrimine and petasinine) were reported to be found
in P. hybridus [8], the presence of these PAs was also investigated.
This was done by selecting corresponding exact mass tracks in
the chromatogram, by means of MS–MS or MRM experiments to
investigate characteristic fragments corresponding to each of the
different PAs. The characteristic fragments are for all retronecine
type free-base PAs m/z 94, 120 and 138 [13] and for retronecine-
type-N-oxides m/z 136 and 154 [32] and m/z 118 [23] in positive
ionization mode. The PAs 7- and 9-angeloylretronecine-N-oxides
were also available as qualitative reference substances. All of these
studies showed that none of these PAs was present in the investi-
gated not properly puriﬁed P. hybridus extract.
3.2. Matrix effects
It is well known that response in MS detection is signiﬁcantly
inﬂuenced by matrix effects [1]. Especially Electrospray Ionisation
(ESI) is prone to be disturbed by simultaneously eluting matrix
components. The most important interference is that the matrix
components competewith the target analytes for the limited avail-
able surface charges. This leads to suppression of the formation of
ions (ion suppression). This is especially relevant at higher con-
centrations, leading to falsely lower measured analyte levels [33].
In our method development of PA analysis for the P. hybridus
extract Ze 339, a PA-free extract was available. This allowed mea-
suring eachof the reference standards in amatrix solution. Thereby,
matrix effects could be largely avoided, because the matrix effects
of the samplewas allocatedwith the one of the reference solutions.
The signiﬁcance of these effects was demonstrated by the com-
parison of raw material (leaves) from P. hybridus and other plant
material as matrices. In comparison with the P. hybridus extract
Ze 339 for PA determination in P. hybridus leaves, no alkaloid
free matrix material was available. Therefore, preparations from
other (alkaloid free) plants served as a substitute matrix [34]. The
effect of different matrices is exempliﬁed in Table 7: Three dif-
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Table 7
PA-standards and their recovery in aqueous solution, matrix solution from artichoke leaves and matrix solution from P. hybridus root.
PA Weighted standard(ng/mL) Recovery (%)
Aqueous solution Artichoke matrix P. hybridus matrix
Senkirkine 28.10 99.0 33.6 –
Seneciphylline 30.08 98.9 24.4 –
Senecionine 30.31 97.5 20.8 –
Senecionine-N-oxide 25.43 98.3 30.6 –
Seneciphylline-N-oxide 28.57 99.4 24.8 –
Monocrotaline 30.73 97.0 15.1 27.2
Monocrotaline-N-oxide 31.60 96.0 34.0 28.5
Intermedine 33.77 98.2 19.2 31.9
Lycopsamine 29.59 98.1 18.7 31.8
Retrorsine 25.64 113.0 25.7 31.2
Retrorsine-N-oxide 25.04 96.9 30.6 29.3
Heliotrine 28.96 99.7 31.4 35.7
Heliotrine-N-oxide 29.02 98.3 33.1 35.1
Echimidine 27.93 98.5 34.0 40.1
Table 8
Effect of the use of internal standards (ISTD) on the variability of the assessment of linearity and precision.
Linearity Precision at 20 ppb level
PA r without ISTD r with ISTD RSD without ISTD RSD with ISTD RSD without ISTD RSD with ISTD
Senkirkine 0.99968 0.99970 2.65 2.56 1.94 2.53
Senecionine 0.99987 0.99976 1.73 2.35 3.20 2.72
Senecionine-N-oxide 0.99989 0.99994 1.58 1.18 1.53 2.18
Seneciphylline 0.99960 0.99942 3.02 3.65 1.67 2.72
Seneciphylline-N-oxide 0.99964 0.99962 2.80 2.89 1.24 1.72
r= regression coefﬁcient, ISTD internal standard, RSD= relative standard deviation.
ferent matrices (aqueous solution, artichoke and the P. hybridus
leave matrix) were spiked with PAs, which do not naturally occur
in the plant. These experiments showed ﬁrstly, the signiﬁcant ion
suppression by the presence of matrix components in general (the
recovery remained partly below one third of the absolute input of
the reference substances), and, secondly, the different extend of ion
suppression when using different matrices.
This suggests that using reference standards dissolved in one
standard plant mixture matrix for the analysis of different other
plants (such as described in [34]) or dissolved in amatrix-free solu-
tion (such as in [8]) will result in a signiﬁcant, systematic bias of PA
quantiﬁcation.
We analysed 29 different batches of the P. hybridus extract Ze
339 for their PA content. None of the tested batches contained
quantiﬁable (e.g. ≥2 ppb) concentrations of unsaturated PAs.
In summary, we have developed a highly sensitive UPLC MS
TOF method with a limit of quantiﬁcation of 2 ppb for all natu-
rally occurring PAs. Recovery at the LOQ was between 88.9 and
141.9%, the repeatability precision between 3.5 and 13.6%. Linear-
ity of the ﬁve PAs showed correlation coefﬁcients between 0.9995
and 0.9998 and coefﬁcients of variation between 7.44 and 8.56%. A
working range between 2ppb and 200ppb could be ﬁxed. It may
be concluded that this assay allows to reliably determine trace PA
concentrations in P. hybridus extract Ze 339, making it suitable for
analytical PA monitoring in accordance with regulatory require-
ments.
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